WCC 2021 | Dalian, China
About WCC-2021 China

BIT's 13th Annual World Cancer Congress (WCC-2021) China will be held during September 25-27, 2021, in Dalian, China.
WCC-2021 is a dedicated event where you will have the opportunity to learn about new developments in the field of cancer research, cancer therapies, and new drug trials, share aspects of your work by submitting an oral presentation, poster, or exhibition. With the participation of outstanding international experts, we hope productive discussions would stimulate new creative ideas to translate discoveries into better practice and application. We hope your participation would contribute to your professional development and relationships. Wish you enjoy the conference.

 
Highlights

20+ Session to talking about the recent advances of Cancer Research

30+ multi-domain Cluster meetings in the fields of Life Science and Medicine

1, 000 Professional Speeches for Basic Research and Clinical Developments

200+ Exhibitors in Cutting-edge Technologies and Novel Products and Poster Show

2,000+ Attendees Coming from all over the World to Exchange Ideas, Build New Networks and Foster Friendships

 
Renowned Speakers of WCC

http://www.bitcongress.com/cancer2015/default_clip_image002.jpg Dr. Thomas Tursz, Professor & Honorary Director, Institut Gustave Roussy, France
Dr. Vladimir LAZAR, Founder and Chief Operating Officer, WIN consortium, France Dr. Alexandra Levine, Chief Medical Officer, Melinda and Norman Payson Professor of Medicine and Professor of Hematology/Transplantation, City of Hope National Medical Center, USA
Dr. Ivan Gout, Professor, University College London, UK Dr. Gerd Birkenmeier, Professor, Institute of Biochemistry, University of Leipzig, Germany Dr. Robert T Chatterton, Professor, Northwestern University Feinberg School of Medicine, USA
Dr. Adhip P. N. Majumdar, Professor & Senior Research Scientist, VA Medical Center/Karmanos Cancer Institute, Wayne State University, USA Dr. Rajesh C. Shrotriya, CEO, Spectrum Pharmaceuticals, Inc., USA Dr. Wim Vanden Berghe, Professor, University Antwerp, Belgium
Dr. Andreas Mandelis, Professor and Director, University of Toronto, Canada Dr. Senyon Choe, Professor of Biology, University of California San Diego, USA Dr. Belamy Cheung, Manager & Senior Lecturer, Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Australia
Dr. Mohamed Aziz, Senior Attending Pathologist/Cytopathologist, North Shore-LIJ Health System, Hofstra North Shore-LIJ School of Medicine, USA Dr. Gian Otto Heinrich Dorta, Professor, CHUV, University Hospital of Lausanne, Switzerland Dr. Antonia Dimitrakopoulou-Strauss, Deputy Head, Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Germany
Dr. Xaveer Van Ostade, Professor, Departement of Biomedical Sciences, University of Antwerp, Belgium Dr. Johannes Haybaeck, Professor, Institute of Pathology, Medical University of Graz, Austria Dr. Reza-Thierry ELAIDI, Director of Clinical Operations, ARTIC, France
Dr. Thomas Grundström, Professor, Department of Molecular Biology, Umeå University, Sweden Dr. Manfred George Krukemeyer, Chairman, Department of Radio-Oncology, Paracelsus-Hospital, Germany Dr. Arun K. Rishi, Professor, Department of Oncology, Karmanos Cancer Institute,  Wayne State University, USA
Dr. Olivier Pardo, Team Leader & Lecturer, Division of Cancer, Imperial College, UK Ms. Donna M. O’Brien, President and CEO, Strategic Visions in Healthcare, LLC., USA Dr. K.S. Rangappa, Professor of Chemistry & Vice-Chancellor, University of Mysore Crawford Hall, India
Dr. Renata Pasqualini, Professor of Internal Medicine & Associate Director, Translational Research, University of New Mexico Cancer Center, USA Dr. Qian-Yun Zhang, Professor of Pathology, University of New Mexico, USA Dr. Xiaoyan Jiang, Professor, Medical Genetics, University of British Columbia & Distinguished Scientist, Terry Fox Laboratory, BC Cancer Research Centre, Canada
Dr. Vikash Sewram, Director & Professor, African Cancer Institute & Stellenbosch University, South Africa Dr. Yanping Zhang, Professor, The University of North Carolina at Chapel Hill, USA Dr. Yi Charlie Chen, Professor of Biology, Alderson Broaddus University, USA

 

Exhibition and Poster

WCC-2021 China Summit -2021 provides an ideal platform to showcase your novel technologies and products. It is developed to offer comfort to delegates while maximizing exhibitor exposure, the coffee breaks and poster sessions will all take place in the exhibition area promoting frequent repeated opportunities for delegates to visit the exhibits.
Why Reserve a Booth at WCC-2021 China Summit -2021
• To Meet Face-to-Face with the International Movers and Shakers
• To Meet with Key Decision Marker
• To Explore Business Opportunities
• To Spotlight Advanced Technologies and Their Scientific and Commercial Applications
• To Take Advantage of the Conference's Captive Audience and Networking Opportunities within the Exhibition Hall

Exhibition Date:
Set-up date: September 24
Show dates: September 25-27, 2021 09:00-18:00
Place: Dalian, China

 
Introduction of Dalian

Dalian — the "Northern Pearl" and summer resort of China, compared to ancient capital cities such as Beijing, Xian, Nanjing or Xi’an, is a young city with only a 100-year history. Dalian is the most relaxed and livable city in Northeast China. In many parts of China, economic prosperity comes at the price of clean air and charm. Not so in Dalian, whose natural blessings are its biggest asset. Tree-lined, hilly streets, dotted colonial architectures, an impressive coastline with beaches, as well as its prosperous town, have made it being dubbed as the "Hong Kong of the North China". It is one of the three Best Tourism Cities (2006), along with Hangzhou and Chengdu, recognized by the National Tourism Administration.

Online Registration
World Class Meeting Venue

WCC-2021 China Summit will be celebrated at Dalian International Conference Center, China

Hosting Organization

BIT Congress Inc.

 
©2016-2021 All right reserved by BIT Congress Inc.
Tel: 0086-411-84799609, Fax: 0086-411-84796897